BACKGROUND/AIMS: Middle East respiratory syndrome coronavirus (MERS-CoV) and Marburg virus (MARV) are among the World Health Organization's top 8 emerging pathogens. Both zoonoses share nonspecific early symptoms, a high lethality rate, and a reduced number of specific treatment options. Therefore, we evaluated extracorporeal virus and glycoprotein (GP) elimination by lectin affinity plasmapheresis (LAP). METHODS: For both MERS-CoV (pseudovirus) as well as MARV (GPs), 4 LAP devices (Mini Hemopurifiers, Aethlon Medical, San Diego, CA, USA) and 4 negative controls were tested. Samples were collected every 30 min and analyzed for reduction in virus infectivity by a flow cytometry-based infectivity assay (MERS-CoV) and in soluble GP content (MARV) by an immunoassay. RESULTS: The experiments show a time-dependent clearance of MERS-CoV of up to 80% within 3 h (pseudovirus). Up to 70% of MARV-soluble GPs were eliminated at the same time. Substantial saturation of the binding resins was detected within the first treatment hour. CONCLUSION: MERS-CoV (pseudovirus) and MARV soluble GPs are eliminated by LAP in vitro. Considering the high lethality and missing established treatment options, LAP should be evaluated in vivo. Especially early initiation, continuous therapy, and timed cartridge exchanges could be of importance. The Author(s). Published by S. Karger AG, Basel.
BACKGROUND/AIMS: Middle East respiratory syndrome coronavirus (MERS-CoV) and Marburg virus (MARV) are among the World Health Organization's top 8 emerging pathogens. Both zoonoses share nonspecific early symptoms, a high lethality rate, and a reduced number of specific treatment options. Therefore, we evaluated extracorporeal virus and glycoprotein (GP) elimination by lectin affinity plasmapheresis (LAP). METHODS: For both MERS-CoV (pseudovirus) as well as MARV (GPs), 4 LAP devices (Mini Hemopurifiers, Aethlon Medical, San Diego, CA, USA) and 4 negative controls were tested. Samples were collected every 30 min and analyzed for reduction in virus infectivity by a flow cytometry-based infectivity assay (MERS-CoV) and in soluble GP content (MARV) by an immunoassay. RESULTS: The experiments show a time-dependent clearance of MERS-CoV of up to 80% within 3 h (pseudovirus). Up to 70% of MARV-soluble GPs were eliminated at the same time. Substantial saturation of the binding resins was detected within the first treatment hour. CONCLUSION:MERS-CoV (pseudovirus) and MARV soluble GPs are eliminated by LAP in vitro. Considering the high lethality and missing established treatment options, LAP should be evaluated in vivo. Especially early initiation, continuous therapy, and timed cartridge exchanges could be of importance. The Author(s). Published by S. Karger AG, Basel.
Authors: Stefan Büttner; Benjamin Koch; Olga Dolnik; Markus Eickmann; Tilo Freiwald; Sarah Rudolf; Jürgen Engel; Stephan Becker; Claudio Ronco; Helmut Geiger Journal: Blood Purif Date: 2015-02-11 Impact factor: 2.614
Authors: Yaseen M Arabi; Awad Al-Omari; Yasser Mandourah; Fahad Al-Hameed; Anees A Sindi; Basem Alraddadi; Sarah Shalhoub; Abdullah Almotairi; Kasim Al Khatib; Ahmed Abdulmomen; Ismael Qushmaq; Ahmed Mady; Othman Solaiman; Abdulsalam M Al-Aithan; Rajaa Al-Raddadi; Ahmed Ragab; Ghaleb A Al Mekhlafi; Abdulrahman Al Harthy; Ayman Kharaba; Mashael Al Ahmadi; Musharaf Sadat; Hanan Al Mutairi; Eman Al Qasim; Jesna Jose; Maliha Nasim; Abdulaziz Al-Dawood; Laura Merson; Robert Fowler; Frederick G Hayden; Hanan H Balkhy Journal: Crit Care Med Date: 2017-10 Impact factor: 7.598
Authors: Ali M Zaki; Sander van Boheemen; Theo M Bestebroer; Albert D M E Osterhaus; Ron A M Fouchier Journal: N Engl J Med Date: 2012-10-17 Impact factor: 91.245
Authors: Kelly L Warfield; Dana L Swenson; Gene G Olinger; Warren V Kalina; M Javad Aman; Sina Bavari Journal: J Infect Dis Date: 2007-11-15 Impact factor: 5.226
Authors: Mitra K Nadim; Lui G Forni; Ravindra L Mehta; Michael J Connor; Kathleen D Liu; Marlies Ostermann; Thomas Rimmelé; Alexander Zarbock; Samira Bell; Azra Bihorac; Vincenzo Cantaluppi; Eric Hoste; Faeq Husain-Syed; Michael J Germain; Stuart L Goldstein; Shruti Gupta; Michael Joannidis; Kianoush Kashani; Jay L Koyner; Matthieu Legrand; Nuttha Lumlertgul; Sumit Mohan; Neesh Pannu; Zhiyong Peng; Xose L Perez-Fernandez; Peter Pickkers; John Prowle; Thiago Reis; Nattachai Srisawat; Ashita Tolwani; Anitha Vijayan; Gianluca Villa; Li Yang; Claudio Ronco; John A Kellum Journal: Nat Rev Nephrol Date: 2020-10-15 Impact factor: 28.314
Authors: Cynthia M Magro; Justin Mulvey; Jeffrey Kubiak; Sheridan Mikhail; David Suster; A Neil Crowson; Jeffrey Laurence; Gerard Nuovo Journal: Ann Diagn Pathol Date: 2020-10-13 Impact factor: 2.090
Authors: Annick Barre; Els J M Van Damme; Mathias Simplicien; Sophie Le Poder; Bernard Klonjkowski; Hervé Benoist; David Peyrade; Pierre Rougé Journal: Cells Date: 2021-06-28 Impact factor: 6.600